litlas
ログインアカウント作成

Mathew S. Maurer

2002–2025 年に発表

158
論文数
21,199
被引用数
71
h 指数
141
i10 指数

被引用数

Mathew S. Maurer の年別被引用数1996 年: 被引用 1 件2002 年: 被引用 1 件2004 年: 被引用 11 件2005 年: 被引用 16 件2006 年: 被引用 28 件2007 年: 被引用 22 件2008 年: 被引用 23 件2009 年: 被引用 34 件2010 年: 被引用 33 件2011 年: 被引用 19 件2012 年: 被引用 38 件2013 年: 被引用 46 件2014 年: 被引用 78 件2015 年: 被引用 86 件2016 年: 被引用 112 件2017 年: 被引用 131 件2018 年: 被引用 110 件2019 年: 被引用 429 件2020 年: 被引用 790 件2021 年: 被引用 1,265 件2022 年: 被引用 914 件2023 年: 被引用 605 件2024 年: 被引用 1,176 件2025 年: 被引用 744 件2026 年: 被引用 19 件1997〜2001 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,133 件、この内訳の 25.9%イタリア: 引用元論文 666 件、この内訳の 8.1%イギリス: 引用元論文 614 件、この内訳の 7.4%ドイツ: 引用元論文 442 件、この内訳の 5.4%中国: 引用元論文 378 件、この内訳の 4.6%カナダ: 引用元論文 292 件、この内訳の 3.5%フランス: 引用元論文 290 件、この内訳の 3.5%日本: 引用元論文 264 件、この内訳の 3.2%スペイン: 引用元論文 260 件、この内訳の 3.2%オランダ: 引用元論文 251 件、この内訳の 3%オーストラリア: 引用元論文 201 件、この内訳の 2.4%ブラジル: 引用元論文 164 件、この内訳の 2%
0%25.9%その他 27.8%

機関

分野

  • Medicine58.6%
  • Biochemistry, Genetics and Molecular Biology32.5%
  • Health Professions2.9%
  • Engineering1.4%
  • Computer Science0.8%
  • Immunology and Microbiology0.7%
  • その他3.1%

トピック

  • Amyloidosis: Diagnosis, Treatment, Outcomes9.7%
  • Cardiovascular Function and Risk Factors5.6%
  • COVID-19 Clinical Research Studies5.5%
  • Long-Term Effects of COVID-194%
  • Parathyroid Disorders and Treatments3.9%
  • Heart Failure Treatment and Management3.4%
  • その他67.9%

共著者

全論文

検索で開く
  1. Extrapulmonary manifestations of COVID-19

    著者: Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan, Tejasav S. Sehrawat, Behnood Bikdeli, Neha Ahluwalia, John C. Ausiello, Elaine Y. Wan, Daniel E. Freedberg, Ajay J. Kirtane, Sahil A. Parikh, Mathew S. Maurer, Anna S. Nordvig, Domenico Accili, Joan M. Bathon, Sumit Mohan, Kenneth A. Bauer, Martin B. Leon, Harlan M. Krumholz, Nir Uriel, Mandeep R. Mehra, Mitchell S.V. Elkind, Gregg W. Stone, Allan Schwartz, David D. Ho, John P. Bilezikian, Donald W. Landry - Nature Medicine 2020 被引用: 3,304

  2. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

    著者: Julian D. Gillmore, Daniel P. Judge, Francesco Cappelli, Marianna Fontana, Pablo García‐Pavía, Simon Gibbs, Martha Grogan, Mazen Hanna, James E. Hoffman, Ahmad Masri, Mathew S. Maurer, José Nativi-Nicolau, Laura Obici, Steen Hvitfeldt Poulsen, Frank W. Rockhold, Keyur B. Shah, Prem Soman, Jyotsna Garg, Karen Chiswell, Haolin Xu, Xiaofan Cao, Ted Lystig, Uma Sinha, Jonathan C. Fox - New England Journal of Medicine 2024 被引用: 461

  3. Transthyretin Amyloid Cardiomyopathy

    著者: Frederick L. Ruberg, Martha Grogan, Mazen Hanna, Jeffery W. Kelly, Mathew S. Maurer - Journal of the American College of Cardiology 2019 被引用: 1,049

  4. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

    著者: Mathew S. Maurer, Parag Kale, Marianna Fontana, John L. Berk, Martha Grogan, Finn Gustafsson, Rebecca R. Hung, Robert Gottlieb, Thibaud Damy, Alejandra González‐Duarte, Nitasha Sarswat, Yoshiki Sekijima, Nobuhiro Tahara, Mark Taylor, Miloš Kubánek, Erwan Donal, Tomáš Paleček, Kenichi Tsujita, W.H. Wilson Tang, WEN‐CHUNG YU, Laura Obici, Marcus Vinı́cius Simões, Fábio Fernandes, Steen Hvitfeldt Poulsen, Igor Diemberger, Federico Perfetto, Scott D. Solomon, Marcelo F. Di Carli, Prajakta Badri, Matthew T. White, Jihong Chen, Elena Yureneva, Marianne T. Sweetser, Patrick Y. Jay, Pushkal Garg, John Vest, Julian D. Gillmore - New England Journal of Medicine 2023 被引用: 307

  5. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

    著者: M. Kittleson, Mathew S. Maurer, Amrut V. Ambardekar, Renée P. Bullock-Palmer, Patricia P. Chang, Howard J. Eisen, Ajith Nair, José Nativi-Nicolau, Frederick L. Ruberg - Circulation 2020 被引用: 717

  6. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

    著者: Marianna Fontana, John L. Berk, Julian D. Gillmore, Ronald Witteles, Martha Grogan, Brian Drachman, Thibaud Damy, Pablo García‐Pavía, Jörg Täubel, Scott D. Solomon, Farooq H. Sheikh, Nobuhiro Tahara, José González‐Costello, Kenichi Tsujita, Caroline Morbach, Zoltán Pozsonyi, Mark C. Petrie, Diego Delgado, Peter van der Meer, Andrew Jabbour, Antoine Bondue, Darae Kim, Olga Azevedo, Steen Hvitfeldt Poulsen, Ali Abbas Yılmaz, Ewa A. Jankowska, Vincent Algalarrondo, Andrew Slugg, Pushkal Garg, Katherine L. Boyle, Elena Yureneva, Nancy Silliman, Lilli Yang, Jihong Chen, Satish A. Eraly, John Vest, Mathew S. Maurer - New England Journal of Medicine 2024 被引用: 362

  7. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

    著者: Adam Castaño, David L. Narotsky, Nadira Hamid, Omar Khalique, Rachelle Morgenstern, Albert J. DeLuca, Jonah Rubin, Codruța Chiuzan, Tamim Nazif, Torsten Vahl, Isaac George, Susheel Kodali, Martin B. Leon, Rebecca T. Hahn, Sabahat Bokhari, Mathew S. Maurer - European Heart Journal 2017 被引用: 721

  8. Frailty Assessment in the Cardiovascular Care of Older Adults

    著者: Jonathan Afilalo, Karen P. Alexander, Michael J. Mack, Mathew S. Maurer, Philip Green, Larry A. Allen, Jeffrey J. Popma, Luigi Ferrucci, Daniel E. Forman - Journal of the American College of Cardiology 2013 被引用: 1,152

  9. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

    著者: Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles, Brian Drachman, Daniel P. Judge, Daniel J. Lenihan, Stephen S. Gottlieb, Sanjiv J. Shah, D. Eric Steidley, Hector Ventura, Srinivas Murali, Marc A. Silver, Daniel Jacoby, Savitri Fedson, Scott L. Hummel, Arnt V. Kristen, Thibaud Damy, Violaine Planté‐Bordeneuve, Teresa Coelho, Rajiv Mundayat, Ole B. Suhr, Márcia Waddington‐Cruz, Claudio Rapezzi - Journal of the American College of Cardiology 2016 被引用: 534

  10. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

    著者: Scott D. Solomon, David Adams, Arnt V. Kristen, Martha Grogan, Alejandra González‐Duarte, Mathew S. Maurer, Giampaolo Merlini, Thibaud Damy, Michel Slama, Thomas H. Brannagan, Angela Dispenzieri, John L. Berk, Amil M. Shah, Pushkal Garg, Akshay Vaishnaw, Verena Karsten, Jihong Chen, Jared Gollob, John Vest, Ole B. Suhr - Circulation 2019 被引用: 461

  11. Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease

    著者: Pierre Elias, Timothy J. Poterucha, Vijay Rajaram, Luca Matos Moller, Victor Rodriguez, Shreyas Bhave, Rebecca T. Hahn, Geoffrey H. Tison, Sean Abreau, Joshua Barrios, Jessica Nicole Torres, J. Weston Hughes, Marco Pérez, Joshua Finer, Susheel Kodali, Omar Khalique, Nadira Hamid, Allan Schwartz, Shunichi Homma, Deepa Kumaraiah, David J. Cohen, Mathew S. Maurer, Andrew J. Einstein, Tamim Nazif, Martin B. Leon, Adler Perotte - Journal of the American College of Cardiology 2022 被引用: 142

  12. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis

    著者: Mathew S. Maurer, Sabahat Bokhari, Thibaud Damy, Sharmila Dorbala, Brian Drachman, Marianna Fontana, Martha Grogan, Arnt V. Kristen, Isabelle Lousada, José Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Ronald Witteles, Giampaolo Merlini - Circulation Heart Failure 2019 被引用: 546

  13. Nutrition Assessment and Dietary Interventions in Heart Failure

    著者: Elissa Driggin, Laura Cohen, Dympna Gallagher, Wahida Karmally, Thomas M. Maddox, Scott L. Hummel, Salvatore Carbone, Mathew S. Maurer - Journal of the American College of Cardiology 2022 被引用: 122

  14. Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis

    著者: Richard K. Cheng, Wayne C. Levy, Alexi Vasbinder, Sergio Teruya, Jeffeny De Los Santos, Douglas Leedy, Mathew S. Maurer - JACC CardioOncology 2020 被引用: 139

  15. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction

    著者: Jesse D. Cochran, Yoshimitsu Yura, Mark C. Thel, Heather Doviak, Ariel H. Polizio, Yuka Arai, Yohei Arai, Keita Horitani, Eunbee Park, Nicholas W. Chavkin, Anupreet Kour, Soichi Sano, Nitin Mahajan, Megan A. Evans, Mahalia Huba, Nadia Martínez Naya, Hanna Sun, Young Ho Ban, Karen K. Hirschi, Stefano Toldo, Antonio Abbate, Todd E. Druley, Frederick L. Ruberg, Mathew S. Maurer, Justin A. Ezekowitz, Jason R.B. Dyck, Kenneth Walsh - Circulation 2023 被引用: 63

  16. Meta‐Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction

    著者: Jonathan D. Rich, Jacob A. Burns, Benjamin H. Freed, Mathew S. Maurer, Daniel Burkhoff, Sanjiv J. Shah - Journal of the American Heart Association 2018 被引用: 184

  17. ATTR Amyloidosis: Current and Emerging Management Strategies

    著者: Jan M. Griffin, Julie Rosenthal, Justin L. Grodin, Mathew S. Maurer, Martha Grogan, Richard K. Cheng - JACC CardioOncology 2021 被引用: 164

  18. 99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

    著者: Sabahat Bokhari, Adam Castaño, Ted Pozniakoff, Susan Deslisle, F. Latif, Mathew S. Maurer - Circulation Cardiovascular Imaging 2013 被引用: 619

  19. Home-Delivered Meals Postdischarge From Heart Failure Hospitalization

    著者: Scott L. Hummel, Wahida Karmally, Brenda W. Gillespie, Stephen Helmke, Sergio Teruya, Joanna Wells, Erika Trumble, Omar Jimenez, Cara Marolt, Jeffrey D. Wessler, Maria L. Cornellier, Mathew S. Maurer - Circulation Heart Failure 2018 被引用: 158

  20. Impact of Vutrisiran on Exploratory Cardiac Parameters in Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    著者: Pablo García‐Pavía, Martha Grogan, Parag Kale, John L. Berk, Mathew S. Maurer, Isabel Conceição, Marcelo F. Di Carli, Scott D. Solomon, Chongshu Chen, Elena Yureneva, John Vest, Julian D. Gillmore - European Journal of Heart Failure 2024 被引用: 52

  21. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy

    著者: Claudio Rapezzi, Perry Elliott, Thibaud Damy, José Nativi-Nicolau, John L. Berk, Eric J. Velazquez, Kurt Boman, Balarama Gundapaneni, Terrell A. Patterson, Jeffrey H. Schwartz, Marla B. Sultan, Mathew S. Maurer - JACC Heart Failure 2020 被引用: 119

  22. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

    著者: Daniel P. Judge, Arnt V. Kristen, Martha Grogan, Mathew S. Maurer, Rodney H. Falk, Mazen Hanna, Julian D. Gillmore, Pushkal Garg, Akshay Vaishnaw, Jamie Harrop, Christine Powell, Verena Karsten, Xiaoping Zhang, Marianne T. Sweetser, John Vest, Philip N. Hawkins - Cardiovascular Drugs and Therapy 2020 被引用: 106

  23. Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

    著者: Sanjiv J. Shah, Nowell M. Fine, Pablo García‐Pavía, Allan L. Klein, Fábio Fernandes, Neil J. Weissman, Mathew S. Maurer, Kurt Boman, Balarama Gundapaneni, Marla B. Sultan, Perry Elliott - JAMA Cardiology 2023 被引用: 74

  24. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

    著者: Adam Castaño, Brian Drachman, Daniel P. Judge, Mathew S. Maurer - Heart Failure Reviews 2014 被引用: 249